国家临床重点专科临床药学评审标准存在的问题及其建议  

Problems and Suggestions on the Assessment Standards of Clinical Pharmacy of National Clinical Key Specialty

作　　者：张红旭[1] 杨庆[1] 牛立营 郭辉[1] 

机构地区：[1]江苏省徐州市肿瘤医院,徐州221005 [2]辽宁大连维特奥国际医院,大连116600

出　　处：《中国药事》2016年第10期1033-1036,共4页Chinese Pharmaceutical Affairs

摘　　要：目的:为修改国家临床重点专科临床药学评审标准,促进我国临床药学专业健康发展提供建议。方法:通过分析国家临床重点专科临床药学评审标准存在的问题,提出评审标准应分为基础条件、信息化管理、门诊病人用药监护、住院病人用药监护、ADR监测、临床药学质量控制标准、科研与教学等内容。结果:国家临床重点专科临床药学评审标准设置中,有些条款模糊不清,具体条款不能针对性地解决目前临床药学专业发展中的工作程序、质量控制以及病区药学监护的工作难点。结论:国家临床重点专科临床药学评审标准设置应当遵循临床药学工作特点,从最关键问题、最薄弱环节入手,才是国家临床重点专科临床药学评审的工作方向。Objective： To put forward suggestions for the modification of the assessment standards of clinical pharmacy of national clinical key specialty, so as to promote the healthy development of clinical pharmacy in our country. Methods： By analyzing the existing problems of the assessment standards of clinical pharmacy of national clinical key specialty, it was suggested that the assessment standard should include such aspects as basic conditions, information management, outpatient pharmacy care, inpatient pharmacy care, ADR monitoring, quality control standards of clinical pharmacy, and scientific research and teaching. Results： Some articles in the assessment standards were vague, as a result, they could not effectively solve the problems in the clinical pharmacy work procedure and quality control as well as difficulties in ward pharmacy care in the development of current clinical pharmacy. Conclusion： The standard settings should comply with the characteristics of clinical pharmacy work and aim at the most critical problems and weak links in practice.

关 键 词：国家临床重点专科 临床药学 评审标准 问题 建议 

分 类 号：R951[医药卫生—药学]